NZ$35.86
0.31%
New Zealand Exchange, Fri, Oct 24 2025
ISIN
NZFAPE0001S2
Symbol
FPH

Fisher & Paykel Healthcare Target price 2025 - Analyst rating & recommendation

Fisher & Paykel Healthcare Classifications & Recommendation:

Buy
40%
Hold
47%
Sell
13%

Fisher & Paykel Healthcare Price Target

Target Price NZ$39.60
Price NZ$35.86
Potential
Number of Estimates 12
12 Analysts have issued a price target Fisher & Paykel Healthcare 2026 . The average Fisher & Paykel Healthcare target price is NZ$39.60. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 15 analysts: 6 Analysts recommend Fisher & Paykel Healthcare to buy, 7 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Fisher & Paykel Healthcare stock has an average upside potential 2026 of . Most analysts recommend the Fisher & Paykel Healthcare stock at Hold.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Mar '25 2026
Estimates
Revenue Billion NZ$ 2.02 2.27
15.96% 12.32%
Net Margin 18.66% 19.23%
145.31% 3.03%

15 Analysts have issued a sales forecast Fisher & Paykel Healthcare 2026 . The average Fisher & Paykel Healthcare sales estimate is

NZ$2.3b
Unlock
. This is
12.32% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
NZ$2.4b 18.31%
Unlock
, the lowest is
NZ$2.2b 7.72%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 NZ$2.0b 15.96%
2026
NZ$2.3b 12.32%
Unlock
2027
NZ$2.5b 11.59%
Unlock
2028
NZ$2.8b 11.57%
Unlock

15 Fisher & Paykel Healthcare Analysts have issued a net profit forecast 2026. The average Fisher & Paykel Healthcare net profit estimate is

NZ$437m
Unlock
. This is
15.73% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
NZ$464m 22.97%
Unlock
, the lowest is
NZ$408m 8.08%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 NZ$377m 184.46%
2026
NZ$437m 15.73%
Unlock
2027
NZ$514m 17.67%
Unlock
2028
NZ$604m 17.53%
Unlock

Net Margin

2025 18.66% 145.31%
2026
19.23% 3.03%
Unlock
2027
20.28% 5.46%
Unlock
2028
21.36% 5.33%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Mar '25 2026
Estimates
Earnings Per Share NZ$ 0.64 0.75
178.26% 17.19%
P/E 47.98
EV/Sales 9.01

15 Analysts have issued a Fisher & Paykel Healthcare forecast for earnings per share. The average Fisher & Paykel Healthcare EPS is

NZ$0.75
Unlock
. This is
17.19% higher
Unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
NZ$0.79 23.44%
Unlock
, the lowest is
NZ$0.70 9.38%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 NZ$0.64 178.26%
2026
NZ$0.75 17.19%
Unlock
2027
NZ$0.88 17.33%
Unlock
2028
NZ$1.03 17.05%
Unlock

P/E ratio

Current 55.86 54.63%
2026
47.98 14.11%
Unlock
2027
40.78 15.01%
Unlock
2028
34.69 14.93%
Unlock

Based on analysts' sales estimates for 2026, the Fisher & Paykel Healthcare stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 10.12 11.92%
2026
9.01 11.01%
Unlock
2027
8.07 10.38%
Unlock
2028
7.23 10.37%
Unlock

P/S ratio

Current 10.17 11.38%
2026
9.05 10.97%
Unlock
2027
8.11 10.38%
Unlock
2028
7.27 10.37%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today